wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q37362796-725C7919-B534-4969-B5A4-8968141BC8C3
Q37362796-725C7919-B534-4969-B5A4-8968141BC8C3
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37362796-725C7919-B534-4969-B5A4-8968141BC8C3
Potential options for managing LOX+ ER- breast cancer patients
P2860
Q37362796-725C7919-B534-4969-B5A4-8968141BC8C3
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37362796-725C7919-B534-4969-B5A4-8968141BC8C3
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
de24e0faf98f436f9ebdbda50b8fa2896be3a328
P2860
Phase II Study of Gemcitabine, Carboplatin, and Iniparib As Neoadjuvant Therapy for Triple-Negative and BRCA1/2 Mutation-Associated Breast Cancer With Assessment of a Tumor-Based Measure of Genomic Instability: PrECOG 0105